Literature DB >> 10194686

Efficacy of parenterally or intramammarily administered tilmicosin or ceftiofur against Staphylococcus aureus mastitis during lactation.

W E Owens1, S C Nickerson, C H Ray.   

Abstract

Two antibiotic preparations, tilmicosin and ceftiofur, were tested intramammarily and parenterally against Staphylococcus aureus mastitis in lactating cows. Neither product was effective as a lactating cow treatment at the doses and durations of treatment tested. Injection or infusion of tilmicosin and infusion of ceftiofur resulted in reductions of bacteria present in milk; however, only one quarter treated with infusion of tilmicosin was cured, and no cures were observed for the other treatments. Somatic cell counts were transiently reduced by infusion of ceftiofur and by infusion and injection of tilmicosin; however, they returned to pretreatment values by 28 d posttreatment.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10194686     DOI: 10.3168/jds.S0022-0302(99)75279-3

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

1.  Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.

Authors:  Shuyu Xie; Fenghua Wang; Yan Wang; Luyan Zhu; Zhao Dong; Xiaofang Wang; Xihe Li; Wenzhong Zhou
Journal:  Part Fibre Toxicol       Date:  2011-11-20       Impact factor: 9.400

2.  Treatment of mastitis during lactation.

Authors:  S Pyörälä
Journal:  Ir Vet J       Date:  2009-04-01       Impact factor: 2.146

3.  A non-inferiority study evaluating a new extended-release preparation of tilmicosin injected subcutaneously vs. ceftiofur administered intramammary, as dry-cow therapy in Holstein Friesian cows.

Authors:  Esteban Ortega; Edgar Alfonseca-Silva; Eduardo Posadas; Graciela Tapia; Hector Sumano
Journal:  J Vet Sci       Date:  2020-11       Impact factor: 1.672

4.  Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus.

Authors:  S Taponen; A Jantunen; E Pyörälä; S Pyörälä
Journal:  Acta Vet Scand       Date:  2003       Impact factor: 1.695

5.  Comparative analysis of four commercial on-farm culture methods to identify bacteria associated with clinical mastitis in dairy cattle.

Authors:  Jair C Ferreira; Marilia S Gomes; Erika C R Bonsaglia; Igor F Canisso; Edgar F Garrett; Jamie L Stewart; Ziyao Zhou; Fabio S Lima
Journal:  PLoS One       Date:  2018-03-15       Impact factor: 3.240

6.  Successful treatment of recurrent subclinical mastitis in cows caused by enrofloxacin resistant bacteria by means of the sequential intramammary infusion of enrofloxacin HCl-2H2O and ceftiofur HCl: a clinical trial.

Authors:  Edgar Alfonseca-Silva; Juan Carlos Cruz-Villa; Lilia Gutiérrez; Hector Sumano
Journal:  J Vet Sci       Date:  2021-09-09       Impact factor: 1.672

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.